Magdalena Kolasa

Dr. Magdalena Kolasa

Maj Institute of Pharmacology, Kraków, Małopolskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Agata Faron-GóreckaAgata Faron-Górecka
Agata Faron-Górecka
KLKatarzyna Latocha
Katarzyna Latocha
PPPaulina Pabian
Paulina Pabian
MKMagdalena Kolasa
Magdalena Kolasa
ISIwona Sobczyk-Krupiarz
Iwona Sobczyk-Krupiarz
Marta Dziedzicka-WasylewskaMarta Dziedzicka-Wasylewska
Marta Dziedzicka-Wasylewska
The most important and widely studied role of prolactin (PRL) is its modulation of stress responses during pregnancy and lactation. PRL acts as a neuropeptide to support physiological reproductive responses. The effects of PRL on the nervous system contribute to a wide range of changes in the female brain during pregnancy and the inhibition of the hypothalamic–pituitary axis. All these changes contribute to the behavioral and physiological adaptations of a young mother to enable reproductive success. PRL-driven brain adaptations are also crucial for regulating maternal emotionality and well-being. Hyperprolactinemia (elevated PRL levels) is a natural and beneficial phenomenon during pregnancy and lactation. However, in other situations, it is often associated with serious endocrine disorders, such as ovulation suppression, which results in a lack of offspring. This introductory example shows how complex this hormone is. In this review, we focus on the different roles of PRL in the body and emphasize the results obtained from animal models of neuropsychiatric disorders.

3 February 2013 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
DŻDariusz Żurawek
Dariusz Żurawek
Agata Faron-GóreckaAgata Faron-Górecka
Agata Faron-Górecka
MKMaciej Kuśmider
Maciej Kuśmider
MKMagdalena Kolasa
Magdalena Kolasa
PGPiotr Gruca
Piotr Gruca
Marta Dziedzicka-WasylewskaMarta Dziedzicka-Wasylewska
Marta Dziedzicka-Wasylewska
Rationale Few studies have investigated neurobiological and biochemical differences between stress-resilient and stress-vulnerable experimental animals. Objectives We investigated alterations in mesolimbic dopamine D2 receptor density and mRNA expression level in stressed rats at two time points, i.e. after 2 and 5 weeks of chronic mild stress (CMS). Methods We used the chronic mild stress paradigm because it is a well-established animal model of depression. Two groups of stressed rats were distinguished during CMS experiments: (1) stress reactive (70 %), which displayed a decrease in the drinking of a palatable sucrose solution during the stress regimen, and (2) stress resilient (30 %), which exhibited an unaltered drinking profile when compared with the unchallenged control group. [3H]Domperidone was used as a ligand to label dopamine D2 receptors, and a mixture of three specific oligonucleotides was used to evaluate dopamine D2 receptor mRNA changes in various regions of the rat brain. Results CMS strongly affected the mesolimbic dopamine circuit in stress-resilient group after 2 weeks and stress-reactive group of rats after 5 weeks which exhibited a decrease in the level of dopamine D2 receptor protein without alterations in D2 mRNA expression. Stress-resilient animals, but not stress-reactive animals, effectively adapted to the extended stress and coped with it. The increase in D2 mRNA expression returned the dopamine D2 receptor density to control levels in stress-resilient rats after 5 weeks of CMS, but not in stress-reactive animals. Conclusions These results clearly demonstrate that, despite earlier blunting, the activation of dopamine receptor biosynthesis in the dopamine mesoaccumbens system in stress-resilient rats is involved in active coping with stressful experiences, and it exhibits a delay in time.

22 September 2016 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
DZDariusz Zurawek
Dariusz Zurawek
MKMaciej Kusmider
Maciej Kusmider
Agata Faron-GóreckaAgata Faron-Górecka
Agata Faron-Górecka
PGPiotr Gruca
Piotr Gruca
PPPaulina Pabian
Paulina Pabian
Marta Dziedzicka-WasylewskaMarta Dziedzicka-Wasylewska
Marta Dziedzicka-Wasylewska
Prolonged stress perturbs physiological balance of a subject and thus can lead to depression. Nevertheless, some individuals are more resilient to stress than the others. Defining molecular factors underlying resilience to stress may contribute to the development of a new antidepressant strategy based on the restoration of resilient phenotype in depressed subjects. We used chronic mild stress (CMS) paradigm—well-characterized animal model of depression which caused in rats behavioral deficits (anhedonia) manifested by decreased consumption of sucrose solution. CMS also generated a proportion of resilient rats which did not alter sucrose consumption despite being stressed. Recently, regulation of a gene expression associated with microRNA (miRNA) is considered as an important factor modulating biochemical response to stress. Based on our previous work and literature survey, we investigated changes in the expression level of seven miRNAs (i.e., miR-18a-5p, miR-34a-5p, miR-135a-5p, miR-195-5p, miR-320-3p, miR-674-3p, miR-872-5p) in mesocortical circuit—crucially involved in stress response in order to find differences between susceptible and resilient phenotype. Bioinformatic analysis showed that all miRNAs of interest potentially target serotonin transporter (SERT). Chronic stress caused global increase in the expression of the abovementioned miRNAs in ventral tegmental area (VTA) of stressed rats followed by parallel decrease in miRNA expression in prefrontal cortex (PCx). This effect was more profound in resilient than anhedonic animals. Moreover, we observed decreased level of SERT in VTA of resilient rats. Our findings show that mesocortical circuit is involved in the response to stress and this phenomenon is more efficient in resilient animals.


1 January 2019
Verified
Book Chapter
Closed access
Agata Faron-GóreckaAgata Faron-Górecka
Agata Faron-Górecka
MSMarta Szlachta
Marta Szlachta
MKMagdalena Kolasa
Magdalena Kolasa
JSJoanna Solich
Joanna Solich
AGAndrzej Górecki
Andrzej Górecki
Marta Dziedzicka-WasylewskaMarta Dziedzicka-Wasylewska
Marta Dziedzicka-Wasylewska

1 November 2013 in Pharmacological Reports
Verified
Journal Article
Closed access
Agata Faron-GóreckaAgata Faron-Górecka
Agata Faron-Górecka
MKMaciej Kuśmider
Maciej Kuśmider
JSJoanna Solich
Joanna Solich
MKMagdalena Kolasa
Magdalena Kolasa
KSKinga Szafran
Kinga Szafran
Marta Dziedzicka-WasylewskaMarta Dziedzicka-Wasylewska
Marta Dziedzicka-Wasylewska